NCT03867487: SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
- State
- Not started
- Phase
- Phase 2
- People
- 40 planned
- Started
- 1 May 2027
- Primary completion
- 1 Jan 2028
- Arms
- Study intervention
- Results
- None posted
- 8 Mar 2019: Trial registered